Biotechnology - Mergers & Acquisitions, Roche


Popular Filters

Roche invests in Stratos Genomics for “Sequencing by Expansion”

Roche invests in Stratos Genomics for “Sequencing by Expansion”


Swiss pharma major Roche has made a strategic investment in USA-based Stratos Genomics and entered into…

BiotechnologyMergers & AcquisitionsResearchRocheStratos Genomics

Roche in deal with Oryzon to develop epigenetics-based medicines; Buys IQuum

Roche in deal with Oryzon to develop epigenetics-based medicines; Buys IQuum


Swiss drug major Roche has entered to a worldwide collaboration with Spanish functional genomics firm…

BiotechnologyIQuumLicensingMergers & AcquisitionsOncologyORY-1001Oryzon GenomicsRoche

July a strong month for life sciences IPOs and M&A


The life sciences initial public offering (IPO) market continued to heat up in July as six life sciences…

BiotechnologyCubist PharmaceuticalsFinancialMergers & AcquisitionsPerrigoPharmaceuticalRoche

Onyx Pharma rejects Amgen's unsolicited $120 per share takeover offer


Following a day of speculation and rumor on Friday, US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX)…

AmgenBayerBiotechnologyCelgeneMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizerRoche

Amylin said to be attracting several Big Pharma suitors


US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22 per share…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbMerck & CoMergers & AcquisitionsPfizerPharmaceuticalRocheSanofiTakeda Pharmaceuticals

Roche will not extend its tender offer for Illumina


In view of the apparent re-election of the incumbent directors of Illumina (Nasdaq: ILMN), a leading…

BiotechnologyIlluminaMergers & AcquisitionsPharmaceuticalRoche

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis


There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

Roche in epigenetics drug discovery collaboration


USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with…

BiotechnologyConstellation PharmaceuticalsGenentechLicensingMergers & AcquisitionsOncologyPharmaceuticalRoche

Gilead gains US approval for Complera, resolves manufacturing problem and buys Genentech facility


In what were a couple of busy news days for US biotech firm Gilead Sciences (Nasdaq: GILD), the company…

Anti-viralsBiotechnologyCompleraGenentechGilead SciencesJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationRocheTibotec

Back to top